Cargando…

Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment

[Image: see text] Fetal bovine serum (FBS) particles, which mainly consist of bovine serum albumin, have the potential for biological and medical applications as drug carriers. The coacervation of albumin is a common technique for preparing albumin-based particles. The replacement of salt with novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Mochizuki, Chihiro, Nakamura, Junna, Nakamura, Michihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404488/
https://www.ncbi.nlm.nih.gov/pubmed/36033705
http://dx.doi.org/10.1021/acsomega.2c04096
_version_ 1784773651596312576
author Mochizuki, Chihiro
Nakamura, Junna
Nakamura, Michihiro
author_facet Mochizuki, Chihiro
Nakamura, Junna
Nakamura, Michihiro
author_sort Mochizuki, Chihiro
collection PubMed
description [Image: see text] Fetal bovine serum (FBS) particles, which mainly consist of bovine serum albumin, have the potential for biological and medical applications as drug carriers. The coacervation of albumin is a common technique for preparing albumin-based particles. The replacement of salt with novel metal salts such as Cu is an affordable way to embed the metal ion in the albumin-based particles. Further, increased Cu distribution is prevalent in many cancers. Here, we prepared adhesive cell-like FBS–copper phosphate hybrid particles [FBS-Cu(3)(PO(4))(2)], which exhibited toxicity toward cancer cells, with a narrow size distribution under cell culture conditions for preventing tumor progression. FBS-Cu(3)(PO(4))(2) showed peroxidase-like activity. In addition, FBS-Cu(3)(PO(4))(2) was successfully loaded with rhodamine B and conjugated with fluorescein isothiocyanate as models of drugs by coincubation. Thus, we designed a simple preparation method for optimizing FBS-Cu(3)(PO(4))(2) synthesis under cell culture conditions. FBS-Cu(3)(PO(4))(2) has significant potential as an efficient reactive oxygen species generator and drug-delivery agent against cancer cells. Furthermore, the RhoB-loaded FBS-Cu(3)(PO(4))(2) successfully interacted with 4T1 mouse mammary tumor cells and were confirmed to exhibit toxicity.
format Online
Article
Text
id pubmed-9404488
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-94044882022-08-26 Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment Mochizuki, Chihiro Nakamura, Junna Nakamura, Michihiro ACS Omega [Image: see text] Fetal bovine serum (FBS) particles, which mainly consist of bovine serum albumin, have the potential for biological and medical applications as drug carriers. The coacervation of albumin is a common technique for preparing albumin-based particles. The replacement of salt with novel metal salts such as Cu is an affordable way to embed the metal ion in the albumin-based particles. Further, increased Cu distribution is prevalent in many cancers. Here, we prepared adhesive cell-like FBS–copper phosphate hybrid particles [FBS-Cu(3)(PO(4))(2)], which exhibited toxicity toward cancer cells, with a narrow size distribution under cell culture conditions for preventing tumor progression. FBS-Cu(3)(PO(4))(2) showed peroxidase-like activity. In addition, FBS-Cu(3)(PO(4))(2) was successfully loaded with rhodamine B and conjugated with fluorescein isothiocyanate as models of drugs by coincubation. Thus, we designed a simple preparation method for optimizing FBS-Cu(3)(PO(4))(2) synthesis under cell culture conditions. FBS-Cu(3)(PO(4))(2) has significant potential as an efficient reactive oxygen species generator and drug-delivery agent against cancer cells. Furthermore, the RhoB-loaded FBS-Cu(3)(PO(4))(2) successfully interacted with 4T1 mouse mammary tumor cells and were confirmed to exhibit toxicity. American Chemical Society 2022-08-12 /pmc/articles/PMC9404488/ /pubmed/36033705 http://dx.doi.org/10.1021/acsomega.2c04096 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mochizuki, Chihiro
Nakamura, Junna
Nakamura, Michihiro
Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment
title Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment
title_full Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment
title_fullStr Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment
title_full_unstemmed Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment
title_short Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment
title_sort preparation of fetal bovine serum–copper phosphate hybrid particles under cell culture conditions for cancer cell treatment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9404488/
https://www.ncbi.nlm.nih.gov/pubmed/36033705
http://dx.doi.org/10.1021/acsomega.2c04096
work_keys_str_mv AT mochizukichihiro preparationoffetalbovineserumcopperphosphatehybridparticlesundercellcultureconditionsforcancercelltreatment
AT nakamurajunna preparationoffetalbovineserumcopperphosphatehybridparticlesundercellcultureconditionsforcancercelltreatment
AT nakamuramichihiro preparationoffetalbovineserumcopperphosphatehybridparticlesundercellcultureconditionsforcancercelltreatment